Meningococcal vaccine

Known as: Meningococcal vaccines, Vaccine, Meningococcal, Vaccines, Meningococcal 
Any vaccine derived from Neisseria meningitidis whether in whole-cell or acellular form used for prophylaxis against meningitis.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
BACKGROUND Meningococcal conjugate vaccines protect individuals directly, but can also confer herd protection by interrupting… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Complement forms an important arm of innate immunity against invasive meningococcal infections. Binding of the alternative… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2008
Highly Cited
2008
CONTEXT Immunization with a meningococcal tetravalent (serogroup ACWY) glycoconjugate vaccine is recommended for all US… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Neisseria meningitidis binds factor H (fH), a key regulator of the alternative complement pathway. A approximately 29 kD fH… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
In January 2005, a tetravalent meningococcal polysaccharide-protein conjugate vaccine ([MCV4] Menactra, manufactured by Sanofi… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Meningococcal C conjugate (MCC) vaccines were licensed on the basis of serological correlates of protection without efficacy data… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
The introduction of meningococcal C conjugate (MCC) vaccine in the UK in November 1999 as a routine 3 dose infant immunisation… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
CONTEXT Data are limited and conflicting regarding the effectiveness of influenza vaccine in health care professionals… (More)
  • figure I
  • table 1
  • table 3
Is this relevant?
Highly Cited
1999
Highly Cited
1999
CONTEXT Meningococcal disease occurs worldwide, and serogroup B disease accounts for a large proportion of cases. Although… (More)
Is this relevant?
Highly Cited
1995
Highly Cited
1995
The antibody kinetics in sera from 27 adults after three doses of the Norwegian group B meningococcal outer membrane vesicle (OMV… (More)
Is this relevant?